This is a condition in newborns where the blood flow through their lungs doesn't stop working properly after birth. It's like the baby's lungs are still connected to the placenta, causing high blood pressure in the lung arteries. This can lead to blue skin (cyanosis) and breathing problems.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Persistent fetal circulation syndrome, now usually called persistent pulmonary hypertension of the newborn (PPHN), is a serious breathing and circulation problem that starts in the first hours after birth. It happens when a baby's body does not make the normal switch from life in the womb to breathing air. Before birth, the placenta supplies oxygen, so the blood vessels in the lungs stay tight and most blood bypasses the lungs through two natural openings near the heart (the foramen ovale and the ductus arteriosus). At birth those lung vessels should relax so blood can flow through the lungs and pick up oxygen. In PPHN the pressure in the lung vessels stays high (pulmonary hypertension), blood keeps detouring around the lungs, and the baby's oxygen level falls. Babies with PPHN usually have fast or labored breathing and may look blue (cyanosis). A telling feature is that giving more oxygen does not raise their oxygen level as much as expected. PPHN is uncommon, affecting roughly 2 in every 1,000 live births, and it can be life-threatening, which is why it is managed in a neonatal intensive care unit (NICU).
PPHN most often develops alongside another problem that stresses the lungs around the time of birth. These include meconium aspiration (breathing in the baby's first stool before or during delivery), pneumonia or a bloodstream infection (sepsis), respiratory distress syndrome, and a lack of oxygen during labor or delivery. It can also come with structural problems such as a congenital diaphragmatic hernia, an opening in the diaphragm that lets abdominal organs crowd the developing lungs. Sometimes no underlying lung disease is found. Some pregnancy factors are linked to higher risk, including smoking and diabetes. Use of a selective serotonin reuptake inhibitor (SSRI), a common type of antidepressant such as sertraline or fluoxetine, late in pregnancy has been associated with a small increase in risk: in one large analysis the chance rose from about 2 to about 3 in every 1,000 births. It is not clear whether the medicine itself or the underlying depression explains this, and untreated depression carries its own risks, so this is a trade-off to discuss with a prescriber rather than a reason to stop a medicine abruptly. Exposure only in early pregnancy was not linked to PPHN. A very small number of babies have a rare genetic lung condition called alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), in which the tiny blood vessels of the lungs never form properly. It looks like severe PPHN but does not improve with the usual treatments. It is usually linked to changes in a gene called FOXF1, which guides lung blood vessel development, and most often is not inherited.
Doctors suspect PPHN when a newborn has breathing trouble and low oxygen levels that do not improve as expected with oxygen. Pulse oximetry, a sensor clipped to the hand or foot, measures oxygen continuously, and blood gas tests show how well the lungs are exchanging oxygen and carbon dioxide. A gap between the oxygen reading on the right hand and the reading on a foot suggests blood is bypassing the lungs. A chest X-ray looks for lung problems such as pneumonia or meconium aspiration. An echocardiogram, an ultrasound of the heart, confirms the diagnosis. It estimates the pressure in the lung arteries, shows which way blood is flowing through the openings near the heart, checks how well the heart is pumping, and, importantly, rules out a structural heart defect, since several serious heart defects can look very similar and need different treatment. When a baby does not respond to treatment as expected, doctors may test for rarer causes such as ACD/MPV.
Treatment aims to relax the lung blood vessels so blood flows through the lungs again, while supporting the baby until the circulation completes its transition. Care also targets the underlying cause, for example antibiotics for infection or surfactant (a liquid that helps air sacs stay open) when the lungs are immature or damaged. Most babies need oxygen, and many need a breathing machine (ventilator), along with sedation to keep them calm and medicines to support blood pressure. Inhaled nitric oxide, a gas given through the breathing circuit, is the main targeted treatment and the only one approved by the Food and Drug Administration (FDA) for PPHN. It relaxes the lung vessels without lowering blood pressure in the rest of the body. In studies it improved oxygen levels in about half of babies and made it less likely that the most intensive support would be needed, though it did not lower the death rate, and it did not help babies with diaphragmatic hernia. When nitric oxide is not enough, doctors may add other medicines that widen lung vessels, such as sildenafil (sold as Revatio for pulmonary hypertension) or milrinone, which also helps the heart pump; these are used off-label in newborns and rest on smaller studies. For the sickest babies, extracorporeal membrane oxygenation (ECMO), a heart-lung bypass machine that takes over oxygenating the blood, can give the lungs time to recover. ECMO is offered only at specialized centers, so some babies are transferred. For ACD/MPV, the only known route to long-term survival is a lung transplant.
PPHN is an illness of the newborn period rather than a lifelong diagnosis. As the lung vessels relax and the underlying illness is treated, support such as nitric oxide and the ventilator is weaned gradually. The hospital stay can be long and stressful for families, especially if the baby needs a ventilator, ECMO or a transfer to another hospital. Outlook depends largely on the cause and how severe the illness was. Some babies develop chronic lung disease, and between 10 and 30 percent of survivors have some form of later developmental difficulty, such as delays in movement, learning or speech. For that reason, babies who had PPHN usually have follow-up after discharge, which may include developmental checks and visits with specialists, so any problem can be found and supported early. ACD/MPV is the exception to this outlook: without a lung transplant, babies with it have not been known to survive past their first year.
PPHN almost always appears and is treated in the hospital in the first hours or days of life. After discharge, keep follow-up appointments and raise any concerns about breathing, feeding, growth, movement or development with your child's pediatrician. Call 911 if your baby's lips or skin turn blue and the baby is struggling to breathe, grunting, has skin pulling in between the ribs with each breath, or becomes limp or unusually hard to wake. If you are pregnant and take an SSRI antidepressant, talk with your prescriber before making any change; do not stop it suddenly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Persistent Fetal Circulation Syndrome is like, what's helped you, or ask the community a question.